SCHEMBL8290902

SCHEMBL8290902

Fc1cccc(-c2cnoc2-c2c[nH]c3ncncc23)c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 3/20 0.44
BCAT1 P54687 1/20 0.41
CDK2 P24941 6/20 0.41
CCNT1 O60563 3/20 0.41
CDK9 P50750 3/20 0.41
CDC7 O00311 2/20 0.41
CCNE1 P24864 2/20 0.41
DBF4 Q9UBU7 1/20 0.41
RPS6KA5 O75582 1/20 0.40
PIM1 P11309 4/20 0.38
PIM3 Q86V86 2/20 0.38
PIM2 Q9P1W9 2/20 0.38
TBK1 Q9UHD2 2/20 0.38
IKBKE Q14164 1/20 0.38
MAP4K4 O95819 3/20 0.36
GSK3B P49841 3/20 0.36
CLK4 Q9HAZ1 3/20 0.36
IRAK4 Q9NWZ3 3/20 0.36
ROCK2 O75116 2/20 0.36
STK3 Q13188 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4827652 0.86 NEK1 (0.45) CDK2CCNT1CDK9MAP4K4GSK3B
SCHEMBL4829590 0.86 CDC7 (0.51) LRRK2BCAT1CDK2CCNT1CDK9
SCHEMBL4827673 0.85 BCAT1 (0.42) LRRK2BCAT1CDK2CCNT1CDK9
SCHEMBL4831549 0.83 CDK2 (0.50) LRRK2BCAT1CDK2CCNT1CDK9
SCHEMBL4872228 0.83 JAK2 (0.50) LRRK2BCAT1CDK2CCNT1CDK9
SCHEMBL4824451 0.83 BCAT1 (0.41) LRRK2BCAT1CDK2CCNT1CDK9
SCHEMBL4831134 0.83 DYRK1A (0.42) LRRK2BCAT1CDK2CDC7PIM1
SCHEMBL4827380 0.81 NTRK1 (0.50) CDK2CCNT1CDK9NTRK1AXL
SCHEMBL8290894 0.81 RPS6KA5 (0.45) LRRK2CDK9CDC7RPS6KA5PIM1
SCHEMBL4831294 0.81 AXL (0.56) MAP4K4GSK3BCLK4IRAK4ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446199-B2 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-04 US disclosed
US-7446199-B2 Compositions useful as inhibitors of protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2008-11-04 US disclosed
EP-1664043-B1 COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMA (US) 2007-11-14 EP disclosed
WO-2005028475-A2 COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2005-03-31 WO disclosed